Kaida BioPharma
Fort Lauderdale, US · Founded 2022 · Delaware corporation
Founders & leadership
CP
Craig PiersonExecutive
SD
Stephen DunnNamed on SEC filing
Board
SV
Stella VnookBoard director
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 2 rounds · 2023
▶$1.6MraisedSep 2026 · 44 investors · BiotechnologyRule 506(b)
▶$1.6MraisedSep 2026 · 44 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig PiersonExecutive Officer, Director
- Stella VnookDirector
- Richard WarburgDirector
- Offering amount
- $4.1M
- Amount sold
- $1.6M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$4KraisedJun 2023 · 47 investors · BiotechnologyRule 506(b)
▶$4KraisedJun 2023 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen DunnDirector
- Craig PiersonExecutive Officer, Director
- Offering amount
- $4K
- Amount sold
- $4K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Kaida BioPharma raised?
- Kaida BioPharma has disclosed $1.6M raised across 2 rounds.
- Where is Kaida BioPharma headquartered?
- Kaida BioPharma is headquartered in Fort Lauderdale, US.